AstraZeneca says “dosing error” resulted in boosted vaccine trial outcome, justifying claims of “90 percent effective”
Just a few highlights from the article:
Perhaps even more questionable is AstraZeneca’s claim that all serious adverse effects observed during the trial occurred exclusively in participants who received the “placebo” shot.
If we are to believe this shady company, then its experimental Covid-19 vaccine is really awesome, especially when given at only a half dose. It also never causes any harmful side effects, which only occur in people who do not receive the vaccine.
All of this is why SVB Leerink’s Geoffrey Porges called AstraZeneca’s data “hopelessly incomplete.” At best, this company is “embellishing” its results. At worst, it is completely making them up in an attempt to salvage its flailing reputation and maybe even rake in windfall profits.
Perhaps even more questionable is AstraZeneca’s claim that all serious adverse effects observed during the trial occurred exclusively in participants who received the “placebo” shot.
If we are to believe this shady company, then its experimental Covid-19 vaccine is really awesome, especially when given at only a half dose. It also never causes any harmful side effects, which only occur in people who do not receive the vaccine.
All of this is why SVB Leerink’s Geoffrey Porges called AstraZeneca’s data “hopelessly incomplete.” At best, this company is “embellishing” its results. At worst, it is completely making them up in an attempt to salvage its flailing reputation and maybe even rake in windfall profits.
SOURCE URL: https://www.distributednews.com/477899.html
A little tongue in cheek there...but not much. Pfizer will probably be the first they'll actually force on school kids (which doesn't make any sense). Moderna will be the biggest participant early on, I think. AZN's vaccine completely screwed up somebody's spine in trials in a condition that renders people paralyzed permanently. They'll still work it into the mix because they have pretty good lobbyists.